Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement

Journal of Clinical Oncology

Volumn 19, Issue 11, 2001, Pages 2851-2855

  McMasters, K M ^a   Reintgen, D S ^a   Ross, M I ^a   Gershenwald, J E ^a   Edwards, M J ^a   Sober, A ^a   Fenske, N ^a   Glass, F ^a   Balch, C M ^a   Coit, D G ^a  

^a UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER ADJUVANT THERAPY; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; TREATMENT PLANNING;

EID: 0035367072     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.11.2851     Document Type: Review

References (28)

1. Review of sentinel lymph node biopsy and systemic interferon for melanoma: Promising but investigational modalities
2. The argument against sentinel node biopsy for malignant melanoma: Its use should be confined to patients in clinical trials
3. WHO declares lymphatic mapping to be the standard of care for melanoma
4. Technical details of intraoperative lymphatic mapping for early stage melanoma
5. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanoma of the head and neck
6. Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma
7. The orderly progression of melanoma nodal metastases
8. The tumor biology of melanoma nodal metastases
9. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma
10. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma
11. Standardized probe-directed sentinel node dissection in melanoma
12. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid
13. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma
14. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
15. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial - Multicenter Selective Lymphadenectomy Trial Group
16. Cost analysis of sentinel lymph node biopsy as an alternative to elective lymph node dissection in patients with malignant melanoma
17. Morbidity of sentinel lymph node biopsy for melanoma
18. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
19. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma
20. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: A randomized trial - WHO Melanoma Programme
21. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
22. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial
23. Emerging evidence for a survival benefit associated with regional lymph node dissection for melanoma
24. Regional nodal surgery for melanoma impacts recurrence rates and survival
25. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
26. High- and low-dose interferon alpha-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190
27. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system
28. A new American Joint Committee on Cancer staging system for cutaneous melanoma